PMS-HYDROMORPHONE TAB 2MG (Chlorhydrate d'hydromorphone) est un médicament commercialisé au Canada. Retrouvez ici composition, équivalents.
| Substance | Dosage | Pour |
|---|---|---|
| Chlorhydrate d'hydromorphone | 2 mg | — |
| Nom commercial | Dosage | Forme | Prix | P/G |
|---|---|---|---|---|
| APO-HYDROMORPHONE | 2 mg | Comprimé | — | — |
| PMS-HYDROMORPHONE TAB 1MG | 1 mg | Comprimé | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 1 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG | 30 mg | Capsule (à action soutenue) | — | — |
| DILAUDID | 2 mg | Comprimé | — | — |
| HYDROMORPHONE HP 20 | 20 mg | Solution | — | — |
| CHLORHYDRATE D'HYDROMORPHONE INJECTABLE HP 50 USAGE UNIQUE | 50 mg | Solution | — | — |
| APO-HYDROMORPHONE | 4 mg | Comprimé | — | — |
| PMS-HYDROMORPHONE TAB 4MG | 4 mg | Comprimé | — | — |
| CHLORHYDRATE D'HYDROMORPHONE POUR INJECTION USP USAGE UNIQUE | 2 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | 18 mg | Capsule (à action soutenue) | — | — |
| DILAUDID | 4 mg | Comprimé | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP 0,4 MG/ML | 20 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3 mg | Capsule (à action soutenue) | — | — |
| APO-HYDROMORPHONE | 8 mg | Comprimé | — | — |
| PMS HYDROMORPHONE SIROP 1MG/ML | 1 mg | Sirop | — | — |
| CHLORHYDRATE D'HYDROMORPHONE INJECTABLE USP 0,2 MG/ML, USAGE UNIQUE | 20 mg | Solution | — | — |
| HYDROMORPH CONTIN CONTROLLED RELEASE CAPSULE | 4.5 mg | Capsule (à action soutenue) | — | — |
| DILAUDID | 1 mg | Comprimé | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP 0,4 MG/ML | 40 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6 mg | Capsule (à action soutenue) | — | — |
| CHLORHYDRATE D'HYDROMORPHONE INJECTABLE USAGE UNIQUE | 2 mg | Solution | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2 mg | Solution | — | — |
| HYDROMORPH CONTIN CONTROLLED RELEASE CAPSULE | 9 mg | Capsule (à action soutenue) | — | — |
| DILAUDID | 8 mg | Comprimé | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG | 12 mg | Capsule (à action soutenue) | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 | 10 mg | Solution | — | — |
| HYDROMORPHONE HP 10 | 10 mg | Solution | — | — |
| APO-HYDROMORPHONE | 1 mg | Comprimé | — | — |
| PMS-HYDROMORPHONE TAB 8MG | 8 mg | Comprimé | — | — |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2 mg | Solution | — | — |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG | 24 mg | Capsule (à action soutenue) | — | — |
| HYDROMORPHONE HP 50 | 50 mg | Solution | — | — |
| CHLORHYDRATE D'HYDROMORPHONE INJECTABLE HP FORTE | 100 mg | Solution | — | — |
Non. PMS-HYDROMORPHONE TAB 2MG relève de la réglementation des stupéfiants : ordonnance sécurisée, posologie en toutes lettres et durée de prescription limitée.
Oui : 35 médicaments commercialisés au Canada contiennent la même substance active.
La classe pharmacothérapeutique de PMS-HYDROMORPHONE TAB 2MG est identifiée par son code ATC. Son code ATC est N02AA03.